Roche, Chugai Weigh In As Tocilizumab Biosimilars Fail To Hit The Mark In Q3

Pair Of Actemra Biosimilars Available In US; Fresenius Kabi Bags Reimbursement Boost

 
• By Dean Rudge
  
China ADC competition
• Source: Shutterstock

More from Biosimilars

More from Generics Bulletin